JAMA·Sep 1Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV TrialRandomized trial in 131,276 peopleCardiovascular diseasePaper